Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVINE: Bumetanide vs Indapamide in Heart Failure
NCT03709160Phase 4Unknown
- Sponsor
- Centro en Insuficiencia Cardiaca
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bumetanide in heart failure with reduced ejection fraction (HFrEF), sponsored by Centro en Insuficiencia Cardiaca. Status: unknown.
02
Drugs
bumetanide
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03709160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709160.